How many insider declarations has ARCH Venture Fund XI, L.P. filed?

ARCH Venture Fund XI, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is ARCH Venture Fund XI, L.P.'s role?

ARCH Venture Fund XI, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does ARCH Venture Fund XI, L.P. report trades for?

ARCH Venture Fund XI, L.P. reports trades for DA32 Life Science Tech Acquisition Corp..

What is ARCH Venture Fund XI, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 13.5M€ and disposals 0.

← Executives ★ Sign in to follow

AV

ARCH Venture Fund XI, L.P.

Other

·SEC (Form 4)

DA32 Life Science Tech Acquisition Corp.

0

申报总数

0

公司

€1345万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by ARCH Venture Fund XI, L.P.. Director active across 1 company, notably DA32 Life Science Tech Acquisition Corp.. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €13.5m. History available since 30 July 2021. The latest transaction was filed on 30 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to ARCH Venture Fund XI, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

DA32 Life Science Tech Acquisition Corp. (US)

申报2 总计

●

ARCH Venture Fund XI, L.P.

高管2023年7月28日DA32 Life Science Tech Acquisition Corp.

0SEC ↗

1,600,000 股Class A Common StockSEC:0001062993-23-016233:0

▲

ARCH Venture Fund XI, L.P.

高管2021年7月30日DA32 Life Science Tech Acquisition Corp.

US$1600万32SEC ↗

1,600,000 股@ US$10.00100.0% 占其流量Class A Common StockSEC:0000899243-21-031417:0

标准退出：2021年10月28日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AV

ARCH Venture Fund XI, L.P.

Other

·SEC (Form 4)

DA32 Life Science Tech Acquisition Corp.

0

申报总数

0

公司

€1345万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by ARCH Venture Fund XI, L.P.. Director active across 1 company, notably DA32 Life Science Tech Acquisition Corp.. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €13.5m. History available since 30 July 2021. The latest transaction was filed on 30 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.